Table 1.

Patient and disease characteristics at baseline (Protocol 001, N = 74)

Age (y)
    Median (range)60 (39-83)
Gender
    Male38 (51)
    Female36 (49)
CTCL stage
    IB11 (15)
    IIA2 (3)
    IIB19 (26)
    III22 (30)
    IVA16 (21)
    IVB4 (5)
Racial origin
    Asian1 (1.4)
    Black11 (15)
    Other1 (1.4)
    White61 (83)
Time from initial CTCL diagnosis (y)
    Median (range)2.6 (0-27)
Clinical characteristics for exploratory analysis
    Presence of clinically abnormal lymph nodes34 (46)
    Presence of histologically involved lymph nodes19 (26)
    Presence of skin tumor22 (30)
    Presence of Sézary syndrome30 (40)
    Number of prior systemic treatments, median (range)3 (1-12)
Body surface area involvement (%), median (range)
    Patch16 (0-100)
    Plaque6% (0-98)
    Tumor0% (0-92)
SWAT score
    Mean (SD)82 (70)
    Median (range)75 (1.5-366)
Pruritis score
    Mean (SD)6 (2.5)
    Median (range)6 (0-10)
  • NOTE: Values in table are expressed as n (%), unless otherwise noted.